India vaccine malaria platform India

mRNA COVID vaccines are more effective against new Covid variants because…: Makers on India's first mRNA jab

Reading now: 997
www.livemint.com

ANI, “In the context of COVID-19 where there is a constant shift of variant of concerns mRNA vaccine is quickly redesigned."   "...During a previous vaccine and COVID seems to be less effective and then people get worried.

So, this platform gives you an opportunity to quickly rehash your platform to the new variant in a very short time. Other conventional platforms have a more, a bit longer turnaround time to adapt to the new variants, but this one does which is a major advantage," he said. “The west was using only mRNA vaccine for the pandemic, but somehow it never got to other countries." He also said that these vaccines are cost-effective. "The second advantage is the cost of infrastructure.

You can come up with the same million kinds of numbers of doses in a much smaller setup. The flexibility and the lower input costs set us to go for it and we basically want to demonstrate that we can do it," Dr Rao added.

The vaccine platform holds promise for many infectious diseases that India centric like malaria or dengue or tuberculosis. "We also know this particular platform is very useful for other diseases, especially ones that are India centric, like malaria or dengue or tuberculosis because this was not a tested platform before COVID in a big public way.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Brendan Smialowski - Not enough Americans taking advantage of government assistance to pay COVID-19 funeral costs - fox29.com - Usa - Washington - city Washington - county Lafayette
fox29.com
62%
449
Not enough Americans taking advantage of government assistance to pay COVID-19 funeral costs
Activists gather during a vigil in Lafayette Park for nurses who died during the COVID-19 pandemic on January 13, 2022, in Washington, DC. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images) WASHINGTON - The federal government has provided more than $2 billion to help cover funeral costs for more than 300,000 families of people who have died from COVID-19, yet not enough people either know about the access to funding or have applied to get help.According to a report from Kaiser Health News, fewer than half of eligible families have even begun their applications to cover funeral costs, something that has been provided for by the Federal Emergency Management Agency (FEMA) since April 2021. On average, the families that have received funding have obtained an average of $6,500, yet many families are still unaware that the money is still available. To solve this problem, FEMA said in March that it is launching a new campaign to raise awareness about the aid to eligible families. The number of people killed by COVID-19 in the United States reached 1 million, according to data collected by Johns Hopkins University on May 18.While the average amount awarded per death is $6,500, according to FEMA, the COVID-19 Funeral Assistance program provides up to $9,000 per funeral and covers COVID-19 related deaths since Jan.
DMCA